Centre approves transfer of Covaxin technology from Bharat Biotech to Haffkine Institute

Centre has approved the transfer of Covaxin technology from Bharat Biotech to Haffkine Institute. Department of Science & Technology, Government of India, informed Maharashtra government that the approval has been given as per the recommendation of the committee of scientific experts for a period of one year. The move will help Haffkine Bio-pharma Corporation to start production of Covaxin as soon as possible.

Maharashtra Chief Minister Uddhav Thackeray has thanked Prime Minister Narendra Modi for accepting his request and allowing Haffkine Institute to start large scale production of covaxin in the state.


Support Ethical Journalism. Support The Dispatch

The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies